Proresolution therapy for the treatment of delayed healing of diabetic wounds

Keyphrases

• Type 2 Diabetes Mellitus (T2DM) 100%
• Apoptotic Cells 100%
• Delayed Healing 100%
• Diabetic Wound 100%
• Pro-resolution 100%
• Diabetic 66%
• Resolvin D1 (RvD1) 66%
• Docosahexaenoic Acid 66%
• Resolvins 66%
• Inflammation 33%
• Macrophage Phagocytosis 33%
• Diabetes 33%
• Obesity 33%
• Microbes 33%
• Wound Healing 33%
• Macrophages 33%
• Fc Receptor 33%
• Cell Surface Receptor 33%
• Wound Closure 33%
• Endogenous Mediator 33%
• Diabetic Mice 33%
• Macrophage Clearance 33%
• Receptor-mediated 33%
• Limb Amputation 33%
• Thymocytes 33%
• Tissue Necrosis 33%
• Peritonitis 33%
• Enhanced Resolution 33%
• Local Application 33%
• Acute Peritonitis 33%
• Delayed Wound Healing 33%
• Low-grade Inflammation 33%
• Inflammation Resolution 33%
• Global Epidemic 33%
• Pro-resolving Lipid Mediators 33%
• D-series Resolvins 33%
• Apoptotic Macrophages 33%
• Patients with Diabetes 33%
• Recurrent Infections 33%
• Db Mice 33%
• Chronic Non-healing Wounds 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Wound 100%
• Inflammation 60%
• Maturity Onset Diabetes of the Young 60%
• Peritonitis 40%
• Docosahexaenoic Acid 40%
• Diabetes Mellitus 40%
• Db/Db Mouse 20%
• Lipid 20%
• Wound Healing 20%
• Fc Receptor 20%
• Wound Healing Impairment 20%
• Cell Receptor 20%
• Recurrent Infection 20%
• Tissue Necrosis 20%
• Diabetic Obesity 20%
• Epidemic 20%

Immunology and Microbiology

• Macrophage 100%
• Inflammation 75%
• Mediator 50%
• Peritonitis 50%
• Infectious Disease 25%
• Thymocyte 25%
• Wound Healing 25%
• Biosynthesis 25%
• Limb 25%
• Wound Healing Impairment 25%
• Db/Db Mouse 25%
• Fc Receptor 25%
• Phagocytosis 25%
• Infection 25%